Follow the Asker Healthcare Group AB (publ) share price and the full directors' dealings record of the company, a listed issuer based in Finland. Shares are quoted on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, Asker Healthcare Group AB (publ) has logged 51 reports. Market capitalisation: €32.4bn. The latest transaction was disclosed on 11 August 2026 (Sale). Among the most active insiders: Martin Lagerblad. Every trade is free.
51
Insider Decl.
n/a
Thresholds
€1m
8 ops.
Buy Volume
€2bn
31 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Asker Healthcare Group AB (publ) Strong Buy (bullish), based on 5 analysts. Average price target: SEK 97.40.
48Σ signal
Buys €1m€2bn Sells
Fundamental score
Ranked 18,168 of 29,053 companies
44.2
score / 100
Value
40
Quality
49
FCF yld2.6%
Earn yld1.7%
EV/EBITDA20.2x
ROE10%
Gross mgn41%
Net mgn2.9%
Debt/EBITDA3.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
280 shares@ €30,912.39540.029% mcap79.3% of flowAktieFI:A003R822-1
25 of 51 declarations
About Asker Healthcare Group AB (publ)
Asker Healthcare Group AB (publ) is a publicly traded company on the XSTO market, specializing in the healthcare and pharmaceutical sector. It focuses on developing and marketing innovative solutions to enhance healthcare.